Aspen Aerogels (ASPN) PT Lowered to $10 at Canaccord Genuity

Canaccord Genuity analyst George Gianarikas lowered the price target on Aspen Aerogels (NYSE: ASPN) to $10.00 (from $11.00) while maintaining a Buy rating.

The analyst comments "To capture some continued uncertainty, we are adjusting our estimates. As a result, our price target moves to $10 from $11 — or ~11x our 2028E EPS. We are moving from our previous target which was based on 2027 estimates to better reflect the company’s scaled earnings potential. With the median of its comps trading at ~11x, we see this multiple as justified, if not conservative, based on the company's strong growth potential beyond 2027: Aspen's numerous OEM relationships, competitive moat, strong balance sheet, and potential for healthy FCF generation."

You May Also Be Interested In

• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results
• Cantor Fitzgerald Reiterates Overweight Rating on Merlin Labs (MRLN)